Medtronic inks partnership for spinal biologics

Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology. 

Advertisement

Under the agreement Medtronic will act as the exclusive sales agent of MagnetOs for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries, according to a Jan. 7 news release. Kuros Biosciences, which is behind MagnetOs, will support Medtronic’s sales team and be responsible for contracts and partnerships.

MagnetOs bone grafts use NeedleGrip surface technology to aid bone growth in soft issues and a more predictable spinal fusion. 

Connecting Orthopedic Providers with Tools to Lead Impactful Financial Discussions with Patients

Recommended Live Webinar on Apr 24, 2025 12:00 PM - 1:00 PM CDT

Advertisement

Next Up in Biologics

  • Healthcare solutions provider Summit Products Group, based in Dallas, has launched a strategic partnership with regenerative medicine developer NovaBone Products. …

  • From product launches and milestones, here are five updates in orthobiologics since March 28. 1. Lenoss Medical’s OsteoPearl procedure reached…

Advertisement

Comments are closed.